Glutaredoxin and Thioredoxin Enzyme Systems: Catalytic Mechanisms and Physiological Functions

Glutathione and Sulfur Amino Acids in Human Health and Disease

Volumn , Issue , 2008, Pages 121-156

  Sabens, Elizabeth A ^a   Mieyal, John J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glutaredoxin and thioredoxin enzyme systems; Glutaredoxin mechanism of action; GRX expression control

Indexed keywords

EID: 77949780387     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470475973.ch7     Document Type: Chapter

References (160)

1. Hirota, K., Nakamura, H., Masutani, H., Yodoi, J. (2002). Thioredoxin superfamily and thioredoxin-inducing agents. Annals of the New York Academy of Sciences, 957, 189-199.
2. Ziegler, D.M. (1985). Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annual Review of Biochemistry, 54, 305-329.
3. Mieyal, J.J., Srinivasan, U., Starke, D.W., Gravina, S.A, Mieyal, P.A. (1995). Glutathionyl specificity of the thioltransferases: Mechanistic and physiological implications. In Packer, L., and Cadenas, E., Eds., Biothiols in Health and Disease, pp. 305-372. New York: Marcel Dekker.
4. Jacob, C., Knight, I., Winyard, P.G. (2006). Aspects of the biological redox chemistry of cysteine: From simple redox responses to sophisticated signaling pathways. Biological Chemistry, 387, 1385-1397.
5. Shelton, M.D., Chock, P.B., Mieyal, J.J. (2005). Glutaredoxin: Role in reversible protein S-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxidants and Redox Signaling, 7, 348-366.
6. Yang, Y., Jao, S., Nanduri, S., Starke, D.W., Mieyal, J.J., Qin, J. (1998). Reactivity of the human thioltransferase (glutaredoxin) C7S, C25S, C78S, C82S mutant and NMR solution structure of its glutathionyl mixed disulfide intermediate reflect catalytic specificity. Biochemistry, 37, 17145-17156.
7. Holmgren, A. (1985) Thioredoxin. Annual Review of Biochemistry, 54, 237-271.
8. Wilkinson, B., Gilbert, H.F. (2004). Protein disulfide isomerase. Biochimica et Biophysica Acta, 1699, 35-44.
9. Powis, G., Montfort, W.R. (2001). Properties and biological activities of thioredoxins. Annual Review of Pharmacology and Toxicology, 41, 261-295.
10. Lillig, C.H., Holmgren, A. (2007). Thioredoxin and related molecules: From biology to health and disease. Antioxidants and Redox Signaling, 9, 25-47.
11. Klatt, P., Lamas, S. (2000). Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. European Journal of Biochemistry, 267, 4928-4944.
12. Berndt, C., Lillig, C.H., Holmgren, A. (2007). Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: Implications for diseases in the cardiovascular system. American Journal of Physiology. Heart and Circulatory Physiology, 292, H1227-H1236.
13. Mieyal, J.J., Starke, D.W., Gravina, S.A., Hocevar, B.A. (1991). Thioltransferase in human red blood cells: Kinetics and equilibrium. Biochemistry, 30, 8883-8891.
14. Starke, D.W., Chen, Y., Bapna, C.P., Lesnefsky, E.J., Mieyal, J.J. (1997). Sensitivity of protein sulfhydryl repair enzymes to oxidative stress. Free Radical Biology and Medicine, 23, 373-384.
15. Pai, H.V., Starke, D.W., Lesnefsky, E.J., Hoppel, C.L., Mieyal, J.J. (2007). What is the functional significance of the unique localization of glutaredoxin 1 (Grx1) in the intermembrane space of mitochondria? Antioxidants and Redox Signaling, 9(11), 2027-2033.
16. Gallogly, M.M., Mieyal, J.J. (2007). Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Current Opinion in Pharmacology, 7(4), 381-391.
17. Rozell, B., Barcena, J.A., Martinez-Galisteo, E., Padilla, C.A., Holmgren, A. (1993). Immunochemical characterization and tissue distribution of glutaredoxin (thioltransferase) from calf. European Journal of Cell Biology, 62, 314-323.
18. Lysell, J., Stjernholm, V.Y., Ciarlo, N., Holmgren, A., Sahlin, L. (2003). Immunohistochemical determination of thioredoxin and glutaredoxin distribution in the human cervix, and possible relation to cervical ripening. Gynecological Endocrinology, 17, 303-310.
19. Sahlin, L.,Wang, H., Stjernholm, Y., Lundberg, M., Ekman, G., Holmgren, A., Eriksson, H. (2000). The expression of glutaredoxin is increased in the human cervix in term pregnancy and immediately post-partum, particularly after prostaglandin-induced delivery. Molecular Human Reproduction, 6, 1147-1153.
20. Stavreus-Evers, A., Masironi, B., Landgren, B.M., Holmgren, A., Eriksson, H., Sahlin, L. (2002). Immunohistochemical localization of glutaredoxin and thioredoxin in human endometrium: A possible association with pinopodes. Molecular Human Reproduction, 8, 546-551.
21. Hirota, K., Matsui, M., Murata, M., Takashima, Y., Cheng, F.S., Itoh, T., Fukuda, K., Yodoi, J. (2000). Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochemical and Biophysical Research Communications, 274, 177-182.
22. Gladyshev, V.N., Liu, A., Novoselov, S.V., Krysan, K., Sun, Q.A., Kryukov, V.M., Kryukov, G.V., Lou, M.F. (2001). Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. Journal of Biological Chemistry, 276, 30374-30380.
23. Lundberg, M., Johansson, C., Chandra, J., Enoksson, M., Jacobsson, G., Ljung, J., Johansson, M., Holmgren, A. (2001). Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. Journal of Biological Chemistry, 276, 26269-26275.
24. Lillig, C.H., Berndt, C., Vergnolle, O., Lonn, M.E., Hudemann, C., Bill, E., Holmgren, A. (2005). Characterization of human glutaredoxin 2 as iron-sulfur protein: A possible role as redox sensor. Proceedings of the National Academy of Sciences USA, 102, 8168-8173.
25. Johansson, C., Kavanagh, K.L., Gileadi, O., Oppermann, U. (2007). Reversible sequestration of active site cysteines in a 2Fe-2S-bridged dimer provides a mechanism for glutaredoxin 2 regulation in human mitochondria. Journal of Biological Chemistry, 282, 3077-3082.
26. Rodriguez-Manzaneque, M.T., Ros, J., Cabiscol, E., Sorribas, A., Herrero, E. (1999). Grx5 glutaredoxin plays a central role in protection against protein oxidative damage in Saccharomyces cerevisiae. Molecular and Cellular Biology, 19, 8180-8190.
27. Wingert, R.A., Galloway, J.L., Barut, B., Foott, H., Fraenkel, P., Axe, J.L., Weber, G.J., Dooley, K., Davidson, A.J., Schmid, B., Paw, B.H., Shaw, G.C., Kingsley, P., Palis, J., Schubert, H., Chen, O., Kaplan, J., Zon, L.I. (2005). Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature, 436, 1035-1039.
28. Gravina, S.A., Mieyal, J.J. (1993). Thioltransferase is a specific glutathionyl mixed disulfide oxidoreductase. Biochemistry, 32, 3368-3376.
29. Mannervik, B., Axelsson, K., Sundewall, A.C., Holmgren, A. (1983). Relative contributions of thioltransferase-and thioredoxin-dependent systems in reduction of lowmolecular-mass and protein disulphides. Biochemical Journal, 213, 519-523.
30. Burke-Gaffney, A., Callister, M.E., Nakamura, H. (2005). Thioredoxin: Friend or foe in human disease? Trends in Pharmacological Sciences, 26, 398-404.
31. Powis, G., Mustacich, D., Coon, A. (2000). The role of the redox protein thioredoxin in cell growth and cancer. Free Radical Biology and Medicine, 29, 312-322.
32. Laurent, T.C., Moore, E.C., Reichard, P. (1964). Enzymatic synthesis of deoxyribonucleotides. IV. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. Journal of Biological Chemistry, 239, 3436-3444.
33. Gromer, S., Urig, S., Becker, K. (2004). The thioredoxin system: From science to clinic. Molecular and Cellular Biology, 24, 40-89.
34. Masutani, H., Hirota, K., Sasada, T., Ueda-Taniguchi, Y., Taniguchi, Y., Sono, H., Yodoi, J. (1996). Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax. Immunology Letters, 54, 67-71.
35. Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama, T., Yodoi, J., Taketo, M.M. (1996). Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Developmental Biology, 178, 179-185.
36. Ho, Y.S., Xiong, Y., Ho, D.S., Gao, J., Chua, B.H., Pai, H., Mieyal, J.J. (2007). Targeted disruption of the glutaredoxin 1 gene does not sensitize adult mice to tissue injury induced by ischemia/reperfusion and hyperoxia. Free Radical Biology and Medicine, 43(9), 1299-1312.
37. Spyrou, G., Holmgren, A. (1996). Deoxyribonucleoside triphosphate pools and growth of glutathione-depleted 3T6 mouse fibroblasts. Biochemical and Biophysical Research Communications, 220, 42-46.
38. Watson,W.H., Yang, X., Choi, Y.E., Jones, D.P., Kehrer, J.P. (2004). Thioredoxin and its role in toxicology. Toxicological Sciences, 78, 3-14.
39. Miranda-Vizuete, A., Gustafsson, J.A., Spyrou, G. (1998). Molecular cloning and expression of a cDNA encoding a human thioredoxin-like protein. Biochemical and Biophysical Research Communications, 243, 284-288.
40. Kondo, N., Nakamura, H., Masutani, H., Yodoi, J. (2006). Redox regulation of human thioredoxin network. Antioxidants and Redox Signaling, 8, 1881-1890.
41. Miranda-Vizuete, A., Ljung, J., Damdimopoulos, A.E., Gustafsson, J.A., Oko, R., Pelto-Huikko, M., Spyrou, G. (2001). Characterization of Sptrx, a novel member of the thioredoxin family specifically expressed in human spermatozoa. Journal of Biological Chemistry, 276, 31567-31574.
42. Jimenez, A., Zu, W., Rawe, V.Y., Pelto-Huikko, M., Flickinger, C.J., Sutovsky, P., Gustafsson, J.A., Oko, R., Miranda-Vizuete, A. (2004). Spermatocyte/spermatid-specific thioredoxin-3, a novel Golgi apparatus-associated thioredoxin, is a specific marker of aberrant spermatogenesis. Journal of Biological Chemistry, 279, 34971-34982.
43. Thiele, M., Bernhagen, J. (2005). Link between macrophage migration inhibitory factor and cellular redox regulation. Antioxidants and Redox Signaling, 7, 1234-1248.
44. Laughner, B.J., Sehnke, P.C., Ferl, R.J. (1998). A novel nuclear member of the thioredoxin superfamily. Plant Physiology, 118, 987-996.
45. Kurooka, H., Kato, K., Minoguchi, S., Takahashi, Y., Ikeda, J., Habu, S., Osawa, N., Buchberg, A.M., Moriwaki, K., Shisa, H., Honjo, T. (1997). Cloning and characterization of the nucleoredoxin gene that encodes a novel nuclear protein related to thioredoxin. Genomics, 39, 331-339.
46. Matsuo, Y., Akiyama, N., Nakamura, H., Yodoi, J., Noda, M., Kizaka-Kondoh, S. (2001). Identification of a novel thioredoxin-related transmembrane protein. Journal of Biological Chemistry, 276, 10032-10038.
47. Washburn, M.P., Wells, W.W. (1999). The catalytic mechanism of the glutathionedependent dehydroascorbate reductase activity of thioltransferase (glutaredoxin). Biochemistry, 38, 268-274.
48. Johansson, C., Lillig, C.H., Holmgren, A. (2004). Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. Journal of Biological Chemistry, 279, 7537-7543.
49. Holmgren, A., Johansson, C., Berndt, C., Lonn, M.E., Hudemann, C., Lillig, C.H. (2005). Thiol redox control via thioredoxin and glutaredoxin systems. Biochemical Society Transactions, 33, 1375-1377.
50. Jao, S.C., English Ospina, S.M., Berdis, A.J., Starke, D.W., Post, C.B., Mieyal, J.J. (2006). Computational and mutational analysis of human glutaredoxin (thioltransferase): Probing the molecular basis of the low pKa of cysteine 22 and its role in catalysis. Biochemistry, 45, 4785-4796.
51. Chrestensen, C.A., Starke, D.W., Mieyal, J.J. (2000). Acute cadmium exposure inactivates thioltransferase (glutaredoxin), inhibits intracellular reduction of protein-glutathionylmixed disulfides, and initiates apoptosis. Journal of Biological Chemistry, 275, 26556-26565.
52. Srinivasan, U., Mieyal, P.A., Mieyal, J.J. (1997). pH profiles indicative of rate-limiting nucleophilic displacement in thioltransferase catalysis. Biochemistry, 36, 3199-3206.
53. Holmgren, A. (1979). Glutathione-dependent synthesis of deoxyribonucleotides. Characterization of the enzymatic mechanism of Escherichia coli glutaredoxin. Journal of Biological Chemistry, 254, 3672-3678.
54. Fernandes, A.P., Holmgren, A. (2004). Glutaredoxins: Glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxidants and Redox Signaling, 6, 63-74.
55. Wells, W.W., Yang, Y., Deits, T.L., Gan, Z.R. (1993). Thioltransferases. Advances in Enzymology and Related Areas of Molecular Biology, 66, 149-201.
56. Gladysheva, T.B., Oden, K.L., Rosen, B.P. (1994). Properties of the arsenate reductase of plasmid R773. Biochemistry, 33, 7288-7293.
57. Rosen, B.P. (2002). Biochemistry of arsenic detoxification. FEBS Letters, 529, 86-92.
58. Shi, J., Vlamis-Gardikas, A., Aslund, F., Holmgren, A., Rosen, B.P. (1999). Reactivity of glutaredoxins 1, 2, and 3 from Escherichia coli shows that glutaredoxin 2 is the primary hydrogen donor to ArsC-catalyzed arsenate reduction. Journal of Biological Chemistry, 274, 36039-36042.
59. Gallogly, M.M., Starke, D.W., Leonberg, A.K., Ospina, S.M., Mieyal, J.J. (2008). Kinetic and mechanistic characterization and versatile catalytic properties of mammalian glutaredoxin 2: implications for intracellular roles. Biochemistry, 47, 11144-11157.
60. Hashemy, S.I., Johansson, C., Berndt, C., Lillig, C.H., Holmgren, A. (2007). Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: Effects on structure and activity. Journal of Biological Chemistry, 282, 14428-14436.
61. Untucht-Grau, R., Schirmer, R.H., Schirmer, I., Krauth-Siegel, R.L. (1981). Glutathione reductase from human erythrocytes: Amino-acid sequence of the structurally known FAD-binding domain. European Journal of Biochemistry, 120, 407-419.
62. Vanoni, M.A., Wong, K.K., Ballou, D.P., Blanchard, J.S. (1990). Glutathione reductase: Comparison of steady-state and rapid reaction primary kinetic isotope effects exhibited by the yeast, spinach, and Escherichia coli enzymes. Biochemistry, 29, 5790-5796.
63. Kallis, G.B., Holmgren, A. (1980). Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli. Journal of Biological Chemistry, 255, 10261-10265.
64. Luthman, M., Holmgren, A. (1982). Glutaredoxin from calf thymus: Purification to homogeneity. Journal of Biological Chemistry, 257, 6686-6690.
65. Antoine, M., Boschi-Muller, S., Branlant, G. (2003). Kinetic characterization of the chemical steps involved in the catalytic mechanism of methionine sulfoxide reductase A from Neisseria meningitidis. Journal of Biological Chemistry, 278, 45352-45357.
66. Holmgren, A. (1979). Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. Journal of Biological Chemistry, 254, 9627-9632.
67. Bjornstedt, M., Kumar, S., Holmgren, A. (1995). Selenite and selenodiglutathione: Reactions with thioredoxin systems. Methods in Enzymology, 252, 209-219.
68. Holmgren, A., Lyckeborg, C. (1980). Enzymatic reduction of alloxan by thioredoxin and NADPH-thioredoxin reductase. Proceedings of the National Academy of Sciences USA, 77, 5149-5152.
69. Prestera, T., Zhang, Y., Spencer, S.R.,Wilczak, C.A., Talalay, P. (1993). The electrophile counterattack response: Protection against neoplasia and toxicity. Advances in Enzyme Regulation, 33, 281-296.
70. Buetler, T.M., Gallagher, E.P., Wang, C., Stahl, D.L., Hayes, J.D., Eaton, D.L. (1995). Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicology and Applied Pharmacology, 135, 45-57.
71. Friling, R.S., Bergelson, S., Daniel, V. (1992). Two adjacent AP-1-like binding sites form the electrophile-responsive element of the murine glutathione S-transferase Ya subunit gene. Proceedings of the National Academy of Sciences USA, 89, 668-672.
72. Khanna, S.C., Garg, S.K., Sharma, S.P. (1992). Antioxidant-influenced alterations in glutathione reductase activity in different age groups of male mice. Gerontology, 38, 9-12.
73. Di Simplicio, P., Jensson, H., Mannervik, B. (1989). Effects of inducers of drug metabolism on basic hepatic forms of mouse glutathione transferase. Biochemical Journal, 263, 679-685.
74. Park, J.B., Levine, M. (1997). The human glutaredoxin gene: Determination of its organization, transcription start point, and promoter analysis. Gene, 197, 189-193.
75. Prieto-Alamo, M.J., Jurado, J., Gallardo-Madueno, R., Monje-Casas, F., Holmgren, A., Pueyo, C. (2000). Transcriptional regulation of glutaredoxin and thioredoxin pathways and related enzymes in response to oxidative stress. Journal of Biological Chemistry, 275, 13398-13405.
76. Wells, W.W., Rocque, P.A., Xu, D.P., Meyer, E.B., Charamella, L.J., Dimitrov, N.V. (1995). Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 breast tumor cells. Free Radical Biology and Medicine, 18, 699-708.
77. Kenchappa, R.S., Diwakar, L., Boyd, M.R., Ravindranath, V. (2002). Thioltransferase (glutaredoxin) mediates recovery of motor neurons from excitotoxic mitochondrial injury. Journal of Neurosciences, 22, 8402-8410.
78. Okuda, M., Inoue, N., Azumi, H., Seno, T., Sumi, Y., Hirata, K., Kawashima, S., Hayashi, Y., Itoh, H., Yodoi, J., Yokoyama, M. (2001). Expression of glutaredoxin in human coronary arteries: Its potential role in antioxidant protection against atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology, 21, 1483-1487.
79. Tao, K. (1997). oxyR-dependent induction of Escherichia coli grx gene expression by peroxide stress. Journal of Bacteriology, 179, 5967-5970.
80. Kumar, S., Holmgren, A. (1999). Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters. Carcinogenesis, 20, 1761-1767.
81. Ejima, K., Nanri, H., Araki, M., Uchida, K., Kashimura, M., Ikeda, M. (1999). 17betaestradiol induces protein thiol/disulfide oxidoreductases and protects cultured bovine aortic endothelial cells from oxidative stress. European Journal of Endocrinology, 140, 608-613.
82. Urata, Y., Ihara, Y., Murata, H., Goto, S., Koji, T., Yodoi, J., Inoue, S., Kondo, T. (2006). 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. Journal of Biological Chemistry, 281, 13092-13102.
83. Rosen, C.F., Poon, R., Drucker, D.J. (1995). UVB radiation-activated genes induced by transcriptional and posttranscriptional mechanisms in rat keratinocytes. American Journal of Physiology, 268, C846-C855.
84. Pan, S., Berk, B.C. (2007). Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: Key role for glutaredoxin in the death pathway. Circulation Research, 100, 213-219.
85. Taniguchi, Y., Taniguchi-Ueda, Y., Mori, K., Yodoi, J. (1996). A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Research, 24, 2746-2752.
86. Nakamura, H., Nakamura, K., Yodoi, J. (1997). Redox regulation of cellular activation. Annual Review of Immunology, 15, 351-369.
87. Osborne, S.A., Hawkes, H.J., Baldwin, B.L., Alexander, K.A., Svingen, T., Clarke, F.M., Tonissen, K.F. (2006). The tert-butylhydroquinone-mediated activation of the human thioredoxin gene reveals a novel promoter structure. Biochemical Journal, 398, 269-277.
88. Tomita, M., Okuyama, T., Katsuyama, H., Hidaka, K., Otsuki, T., Ishikawa, T. (2006). Gene expression in rat lungs during early response to paraquat-induced oxidative stress. International Journal of Molecular Medicine, 17, 37-44.
89. Das, K.C., Guo, X.L., White, C.W. (1999). Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen. American Journal of Physiology, 276, L530-L539.
90. Tanito, M., Agbaga, M.P., Anderson, R.E. (2007). Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radical Biology and Medicine, 42, 1838-1850.
91. Barrett, W.C., DeGnore, J.P., Keng, Y.F., Zhang, Z.Y., Yim, M.B., Chock, P.B. (1999). Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. Journal of Biological Chemistry, 274, 34543-34546.
92. Barrett,W.C., DeGnore, J.P., Konig, S., Fales, H.M., Keng, Y.F., Zhang, Z.Y., Yim, M.B., Chock, P.B. (1999). Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry, 38, 6699-6705.
93. Pimentel, D.R., Adachi, T., Ido, Y., Heibeck, T., Jiang, B., Lee, Y., Melendez, J.A., Cohen, R.A., Colucci, W.S. (2006). Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. Journal of Molecular and Cellular Cardiology, 41, 613-622.
94. Ghezzi, P. (2005). Regulation of protein function by glutathionylation. Free Radical Research, 39, 573-580.
95. Kanda, M., Ihara, Y., Murata, H., Urata, Y., Kono, T., Yodoi, J., Seto, S., Yano, K., Kondo, T. (2006). Glutaredoxin modulates platelet-derived growth factor-dependent cell signaling by regulating the redox status of low molecular weight protein-tyrosine phosphatase. Journal of Biological Chemistry, 281, 8518-28528.
96. Wang, J., Boja, E.S., Tan,W., Tekle, E., Fales, H.M., English, S., Mieyal, J.J., Chock, P.B. (2001). Reversible glutathionylation regulates actin polymerization in A431 cells. Journal of Biological Chemistry, 276, 47763-47766.
97. Shelton, M.D., Kern, T.S., Mieyal, J.J. (2007). Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: Model of diabetic retinopathy. Journal of Biological Chemistry, 282(17), 12467-12474.
98. Pineda-Molina, E., Klatt, P., Vazquez, J., Marina, A., Garcia, D.L., Perez-Sala, D., Lamas, S. (2001). Glutathionylation of the p50 subunit of NF-kappaB: A mechanism for redoxinduced inhibition of DNA binding. Biochemistry, 40, 14134-14142.
99. Reynaert, N.L., van der Vliet, A., Guala, A.S., McGovern, T., Hristova, M., Pantano, C., Heintz, N.H., Heim, J., Ho, Y.S., Matthews, D.E., Wouters, E.F., Janssen-Heininger, Y.M. (2006). Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proceedings of the National Academy of Sciences USA, 103, 13086-13091.
100. Adachi, T., Pimentel, D.R., Heibeck, T., Hou, X., Lee, Y.J., Jiang, B., Ido,Y., Cohen, R.A. (2004). S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. Journal of Biological Chemistry, 279, 29857-29862.
101. Kenchappa, R.S., Diwakar, L., Annepu, J., Ravindranath, V. (2004). Estrogen and neuroprotection: Higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration. FASEB Journal, 18, 1102-1104.
102. Giustarini, D., Rossi, R., Milzani, A., Colombo, R., Dalle-Donne, I. (2004). S-glutathionylation: From redox regulation of protein functions to human diseases. Journal of Cellular and Molecular Medicine, 8, 201-212.
103. Wang, J., Tekle, E., Oubrahim, H., Mieyal, J.J., Stadtman, E.R., Chock, P.B. (2003). Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin. Proceedings of the National Academy of Sciences USA, 100, 5103-5106.
104. Zhang, S., Zhang, Z.Y. (2007). PTP1B as a drug target: Recent developments in PTP1B inhibitor discovery. Drug Discovery Today, 12, 373-381.
105. Bandyopadhyay, S., Starke, D.W., Mieyal, J.J., Gronostajski, R.M. (1998). Thioltransferase (glutaredoxin) reactivates the DNA-binding activity of oxidation-inactivated nuclear factor I. Journal of Biological Chemistry, 273, 392-397.
106. Shelton, M.D., Distler, A.M., Kern, T.S., Mieyal, J.J. (2009). Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (Müller) cells. Journal of Biological Chemistry, 284, 4760-4766.
107. Qanungo, S., Starke, D.W., Pai, H.V., Mieyal, J.J., Nieminen, A.L. (2007). Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkB. Journal of Biological Chemistry, 282, 18427-18436.
108. Starke, D.W., Chock, P.B., Mieyal, J.J. (2003). Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase): Potential role in redox signal transduction. Journal of Biological Chemistry, 278, 14607-14613.
109. Pham, F.H., Sugden, P.H., Clerk, A. (2000). Regulation of protein kinase B and 4E-BP1 by oxidative stress in cardiac myocytes. Circulation Research, 86, 1252-1258.
110. Murata, H., Ihara, Y., Nakamura, H., Yodoi, J., Sumikawa, K., Kondo, T. (2003). Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. Journal of Biological Chemistry, 278, 50226-50233.
111. 2. Journal of Biological Chemistry, 277, 6566-46575.
112. Shaulian, E., Karin, M. (2002). AP-1 as a regulator of cell life and death. Nature Cell Biology, 4, E131-E136.
113. Klatt, P., Molina, E.P., De Lacoba, M.G., Padilla, C.A., Martinez-Galesteo, E., Barcena, J.A., Lamas, S. (1999). Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB Journal, 13, 1481-1490.
114. Hurd, T.R., Costa, N.J., Dahm, C.C., Beer, S.M., Brown, S.E., Filipovska, A., Murphy, M.P. (2005). Glutathionylation of mitochondrial proteins. Antioxidants and Redox Signaling, 7, 999-1010.
115. Tretter, L., Sipos, I., Adam-Vizi, V. (2004). Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochemical Research, 29, 569-577.
116. Gandhi, S., Wood, N.W. (2005). Molecular pathogenesis of Parkinson's disease. Human Molecular Genetics, 14(Spec No. 2), 2749-2755.
117. Hurd, T.R., Requejo, R., Filipovska, A., Brown, S., Prime, T.A., Robinson, A.J., Fearnley, I.M., Murphy, M.P. (2008). Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys 531 and Cys 704 of the 75 kDa subunit: potential role of CYS residues in decreasing oxidative damage. Journal of Biological Chemistry, 283, 24801-24815.
118. Kenchappa, R.S., Ravindranath, V. (2003). Glutaredoxin is essential for maintenance of brain mitochondrial complex I: Studies with MPTP. FASEB Journal, 17, 717-719.
119. Diwakar, L., Kenchappa, R.S., Annepu, J., Ravindranath, V. (2007), Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: Implications in excitotoxicity. Neurochemistry International, 51, 37-46.
120. Beer, S.M., Taylor, E.R., Brown, S.E., Dahm, C.C., Costa, N.J., Runswick, M.J., Murphy, M.P. (2004). Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: Implications for mitochondrial redox regulation and antioxidant defense. Journal of Biological Chemistry, 279, 47939-47951.
121. Davis, D.A., Dorsey, K., Wingfield, P.T., Stahl, S.J., Kaufman, J., Fales, H.M., Levine, R.L. (1996). Regulation of HIV-1 protease activity through cysteine modification. Biochemistry, 35, 2482-2488.
122. Davis, D.A., Newcomb, F.M., Starke, D.W., Ott, D.E., Mieyal, J.J., Yarchoan, R. (1997). Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. Journal of Biological Chemistry, 272, 25935-25940.
123. Velu, C.S., Niture, S.K., Doneanu, C.E., Pattabiraman, N., Srivenugopal, K.S. (2007). Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNAbinding domain during oxidative stress. Biochemistry, 46, 7765-7780.
124. Rhee, S.G., Chae, H.Z., Kim, K. (2005). Peroxiredoxins: A historical overviewand speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radical Biology and Medicine, 38, 1543-1552.
125. Chae, H.Z., Chung, S.J., Rhee, S.G. (1994). Thioredoxin-dependent peroxide reductase from yeast. Journal of Biological Chemistry, 269, 27670-27678.
126. Biteau, B., Labarre, J., Toledano, M.B. (2003). ATP-dependent reduction of cysteinesulphinic acid by S. cerevisiae sulphiredoxin. Nature, 425, 980-984.
127. Woo, H.A., Jeong, W., Chang, T.S., Park, K.J., Park, S.J., Yang, J.S., Rhee, S.G. (2005). Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. Journal of Biological Chemistry, 280, 3125-3128.
128. Manevich, Y., Feinstein, S.I., Fisher, A.B. (2004). Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proceedings of the National Academy of Sciences USA, 101, 3780-3785.
129. Bjornstedt, M., Xue, J., Huang, W., Akesson, B., Holmgren, A. (1994). The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. Journal of Biological Chemistry, 269, 29382-29384.
130. Bertini, R., Howard, O.M., Dong, H.F., Oppenheim, J.J., Bizzarri, C., Sergi, R., Caselli, G., Pagliei, S., Romines, B.,Wilshire, J.A., Mengozzi, M., Nakamura, H., Yodoi, J., Pekkari, K., Gurunath, R., Holmgren, A., Herzenberg, L.A., Herzenberg, L.A., Ghezzi, P. (1999). Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. Journal of Experimental Medicine, 189, 1783-1789.
131. Nickel,W. (2003). The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. European Journal of Biochemistry, 270, 2109-2119.
132. Arai, R.J., Masutani, H., Yodoi, J., Debbas, V., Laurindo, F.R., Stern, A., Monteiro, H.P. (2006). Nitric oxide induces thioredoxin-1 nuclear translocation: Possible association with the p21Ras survival pathway. Biochemical and Biophysical Research Communications, 348, 1254-1260.
133. Malik, G., Gorbounov, N., Das, S., Gurusamy, N., Otani, H., Maulik, N., Goswami, S., Das, D.K. (2006). Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway. Antioxidants and Redox Signaling, 8, 2101-2109.
134. Makino, Y., Yoshikawa, N., Okamoto, K., Hirota, K., Yodoi, J., Makino, I., Tanaka, H. (1999). Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. Journal of Biological Chemistry, 274, 3182-3188.
135. Ravi, D., Muniyappa, H., Das, K.C. (2005). Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells. Journal of Biological Chemistry, 280, 40084-40096.
136. Wei, S.J., Botero, A., Hirota, K., Bradbury, C.M., Markovina, S., Laszlo, A., Spitz, D.R., Goswami, P.C., Yodoi, J., Gius, D. (2000). Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Research, 60, 6688-6695.
137. Nakamura, H., Nakamura, K., Yodoi, J. (1997). Redox regulation of cellular activation. Annual Review of Immunology, 15, 351-369.
138. Nordberg, J., Arner, E.S. (2001). Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biology and Medicine, 31, 1287-1312.
139. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., Ichijo, H. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO Journal, 17, 2596-2606.
140. Song, J.J., Lee, Y.J. (2003). Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochemistry Journal, 373, 845-853.
141. Jones, D.P. (2006). Redefining oxidative stress. Antioxidants and Redox Signaling, 8, 1865-1879.
142. Peltoniemi, M.J., Rytila, P.H., Harju, T.H., Soini, Y.M., Salmenkivi, K.M., Ruddock, L.W., Kinnula, V.L. (2006). Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease. Respiration Research, 7, 133.
143. Takagi, Y., Mitsui, A., Nishiyama, A., Nozaki, K., Sono, H., Gon, Y., Hashimoto, N., Yodoi, J. (1999). Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proceedings of the National Academy of Sciences USA, 96, 4131-4136.
144. Lundberg, M., Fernandes, A.P., Kumar, S., Holmgren, A. (2004). Cellular and plasma levels of human glutaredoxin 1 and 2 detected by sensitive ELISA systems. Biochemical and Biophysical Research Communications, 319, 801-809.
145. Olanow, C.W., Tatton, W.G. (1999). Etiology and pathogenesis of Parkinson's disease. Annual Review of Neuroscience, 22, 123-144.
146. Daily, D., Vlamis-Gardikas, A., Offen, D., Mittelman, L., Melamed, E., Holmgren, A., Barzilai, A. (2001). Glutaredoxin protects cerebellar granule neurons from dopamineinduced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun N-terminal kinase pathways. Journal of Biological Chemistry, 276, 21618-21626.
147. Akterin, S., Cowburn, R.F., Miranda-Vizuete, A., Jimenez, A., Bogdanovic, N.,Winblad, B., Cedazo-Minguez, A. (2006). Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death and Differentiation, 13, 1454-1465.
148. Sachi, Y., Hirota, K., Masutani, H., Toda, K., Okamoto, T., Takigawa, M., Yodoi, J. (1995). Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. Immunology Letters, 44, 89-193.
149. Nakamura, H., De Rosa, S.C., Yodoi, J., Holmgren, A., Ghezzi, P., Herzenberg, L.A., Herzenberg, L.A. (2001). Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proceedings of the National Academy of Sciences USA, 98, 2688-2693.
150. Nakamura, H., Herzenberg, L.A., Bai, J., Araya, S., Kondo, N., Nishinaka,Y., Herzenberg, L.A., Yodoi, J. (2001). Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proceedings of the National Academy of Sciences USA, 98, 15143-15148.
151. Aota, M., Matsuda, K., Isow, N., Wada, H., Yodoi, J., Ban, T. (1996). Protection against reperfusion-induced arrhythmias by human thioredoxin. Journal of Cardiovascular Pharmacology, 27, 727-732.
152. Miyamoto, M., Kishimoto, C., Nimata, M., Nakamura, H., Yodoi, J. (2004). Thioredoxin, a redox-regulating protein, is expressed in spontaneous myocarditis in inbred strains of mice. International Journal of Cardiology, 95, 315-319.
153. Tao, L., Gao, E., Hu, A., Coletti, C.,Wang, Y., Christopher, T.A., Lopez, B.L., Koch,W., Ma, X.L. (2006). Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress. British Journal of Pharmacology, 149, 311-318.
154. Kobayashi-Miura, M., Shioji, K., Hoshino, Y., Masutani, H., Nakamura, H., Yodoi, J. (2007). Oxygen sensing and redox signaling: The role of thioredoxin in embryonic development and cardiac diseases. American Journal of Physiology. Heart and Circulatory Physiology, 292, H2040-H2050.
155. Mitsui, A., Hamuro, J., Nakamura, H., Kondo, N., Hirabayashi, Y., Ishizaki-Koizumi, S., Hirakawa, T., Inoue, T., Yodoi, J. (2002). Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxidants and Redox Signaling, 4, 693-696.
156. Takagi, Y., Hattori, I., Nozaki, K., Mitsui, A., Ishikawa, M., Hashimoto, N., Yodoi, J. (2000). Excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice. Journal of Cerebral Blood Flow and Metabolism, 20, 829-833.
157. Masutani, H., Bai, J., Kim, Y.C., Yodoi, J. (2004). Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection. Molecular Neurobiology, 29, 229-242.
158. Asahina, M., Yamada, T., Yoshiyama, Y., Yodoi, J. (1998). Expression of adult T cell leukemia-derived factor in human brain and peripheral nerve tissues. Dementia and Geriatric Cognitive Disorders, 9, 181-185.
159. Weichsel, A., Gasdaska, J.R., Powis, G., Montfort, W.R. (1996). Crystal structures of reduced, oxidized, and mutated human thioredoxins: Evidence for a regulatory homodimer. Structure, 4, 735-751.
160. Sun, C., Berardi, M.J., Bushweller, J.H. (1998). The NMR solution structure of human glutaredoxin in the fully reduced form. Journal of Molecular Biology, 280, 687-701.